glp 1 drugs and addiction Prospects of GLP-1 Therapies for Mental Health Comorbidities-Quo Vadis?: A Review GLP-1 drugs show promise for
Description
Discovery of gastric inhibitory polypeptide and its subsequent fate: personal reflections
Studies have shown that semaglutide upregulates the expression of ITPR1 and ADCY5 in CRC by activating the GLP-1 receptor, which, in turn, inhibits the motility of CRC cells [88]
Targeting GLP-1 receptor trafficking to improve agonist efficacy
Annals of Internal Medicine
The researchers compared exercise alone, exercise plus liraglutide, or liraglutide alone in people without diabetes
doi: 10.1038/nature22378
